NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Anuj Kalsy
Harvard University - Cambridge / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 1410386
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Anuj Kalsy's MOST POPULAR ARTICLES
1-)
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibitionAN Hata, MJ Niederst, HL Archibald, M Gomez-Caraballo, FM Siddiqui, ...Nature medicine 22 (3), 262-269, 20167432016
2-)
Patient-derived models of acquired resistance can identify effective drug combinations for cancerAS Crystal, AT Shaw, LV Sequist, L Friboulet, MJ Niederst, EL Lockerman, ...Science 346 (6216), 1480-1486, 20146812014
3-)
Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR InhibitorT790 Heterogeneity in …Z Piotrowska, MJ Niederst, CA Karlovich, HA Wakelee, JW Neal, ...Cancer discovery 5 (7), 713-722, 20154532015
4-)
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway AlterationsLG Ahronian, EM Sennott, EM Van Allen, N Wagle, EL Kwak, JE Faris, ...Cancer discovery 5 (4), 358-367, 20153282015
5-)
Defective B cell responses in the absence of SH2D1AM Morra, RA Barrington, AC Abadia-Molina, S Okamoto, A Julien, C Gullo, ...Proceedings of the National Academy of Sciences 102 (13), 4819-4823, 20051002005
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept